Trump said he doesn't see a recession after the bond market spooked investors and the Dow suffered its worst day of the year last week.Marketsread more
The U.K. prime minister prepares to meet his German and French counterparts this week.Europe Politicsread more
Amazon is raising seller fees for thousands of small and medium-sized businesses in France because of a new digital tax passed by the French government.Technologyread more
U.S. stock index futures point to a higher open on Monday morning as the White House sought to calm investors over growing concerns about the U.S. economy.US Marketsread more
Ahead of the deadline, U.S. President Donald Trump told reporters that Huawei was a national security threat.Technologyread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
Baidu is gearing up to release its second-quarter earnings on Monday with the market expecting a sharp decline in profit.Technologyread more
Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Stocks in Asia rose on Monday as U.S. Treasury yields bounced higher after plunging last week.Asia Marketsread more
The problem with tanking equities lies elsewhere, writes Michael Ivanovitch, because traders see no end to America's unfolding trade disputes with Europe and China.World Economyread more
Beijing wants to use reforms to support a slowing economy.China Marketsread more
A federal judge is considering halting the integration of CVS Health and Aetna — even though the two companies closed their merger last week.
Judge Richard Leon of the U.S. District Court for the District of Columbia in a hearing Monday floated the idea that CVS and Aetna keep their companies separate until he can determine whether the agreement the Justice Department struck with the companies clears anti-competitive concerns, according to a transcript of the hearing.
The judge pointed to concerns from groups, such as the American Medical Association, that have urged regulators to block the deal, saying the combination would reduce competition and leave consumers worse off.
The Justice Department in October said it would require CVS and Aetna to resolve overlap between their Medicare Part D plans in order to approve their roughly $70 billion deal. To satisfy these concerns, Aetna sold its business to WellCare Health Plans.
When the Justice Department strikes an agreement with companies, the deal must be cleared by a federal judge. This step has become somewhat procedural, with judges rarely questioning or opposing the terms. Companies typically don't wait for a judge to rule before closing a deal. So while it's not unusual for CVS to have already completed its acquisition of Aetna, it is unusual for a judge to consider keeping the companies from integrating while he completes his review.
"Unusual is almost too light of a word," said Andrea Agathoklis Murino, a partner in and co-chair of Goodwin's antitrust and competition law practice. "I can't recall another instance of a judge doing this."
Enacted in 1974, the Tunney Act slows the merger process and adds a layer of oversight in cases where the Justice Department negotiates with the companies seeking to combine. The law created a 60-day comment period and gave judges the final say on whether the agreements made are in the public's best interest.
Under the law, judges can conclude that the remedy proposed does not address anti-competitive concerns outlined in the complaint, said Jim Tierney, a partner in Orrick's antitrust practice. They can't, however, block the entire merger.
That means in the CVS-Aetna case specifically, Leon can decide whether the agreement the Justice Department struck with CVS and Aetna on their Medicare Part D businesses addresses anti-competitive issues, Tierney said. He can find the agreement sufficiently clears these concerns or not. If he finds it does not, the companies can renegotiate with the Justice Department or appeal the ruling.
Leon on Monday said he will order both parties to submit their arguments as to why he should not halt the integration pending his final ruling. He ordered the companies to submit filings by Dec. 14 and called another hearing for Dec. 18.
CVS and Aetna closed their roughly $70 billion deal on Nov. 28.
"CVS Health and Aetna are one company, and our focus is on transforming the consumer health experience," CVS said in a statement.
Correction: This story has been updated to clarify the judge's statement as to what order he will issue.